| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 338.174.107 | 320.380.553 | 345.758.646 | 356.847.656 | 412.217.469 | 427.102.086 | 452.784.120 | 561.984.328 | 414.505.687 | 166.521.446 |
| Venituri Totale - Ron | 350.570.609 | 323.014.595 | 347.939.861 | 359.177.008 | 415.420.849 | 426.051.895 | 460.334.353 | 564.890.863 | 421.748.882 | 174.375.736 |
| Cheltuieli Totale - Ron | 333.106.108 | 308.021.207 | 323.157.392 | 331.898.880 | 399.475.953 | 405.614.156 | 440.790.860 | 541.621.972 | 397.052.500 | 162.918.293 |
| Profit/Pierdere Brut - Ron | 17.464.501 | 14.993.388 | 24.782.469 | 27.278.128 | 15.944.896 | 20.437.739 | 19.543.493 | 23.268.891 | 24.696.382 | 11.457.443 |
| Profit/Pierdere Net - Ron | 16.488.469 | 9.628.798 | 18.490.918 | 21.763.990 | 10.815.508 | 10.541.374 | 17.484.073 | 19.915.618 | 19.311.222 | 9.511.490 |
| Salariati | 284 | 307 | 309 | 320 | 349 | 487 | 498 | 510 | 347 | 357 |
Verifica rapoartele financiare pentru firma - Novartis Pharmaceuticals S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 120.639.124 | 128.441.012 | 133.302.841 | 136.285.036 | 133.643.157 | 160.001.728 | 186.424.169 | 176.785.887 | 163.369.057 | 154.254.945 |
| Active Circulante | 188.166.401 | 197.465.768 | 230.170.594 | 225.336.347 | 253.298.600 | 273.767.317 | 326.068.396 | 347.949.431 | 113.989.055 | 549.755.780 |
| Stocuri | 19.297.182 | 17.304.563 | 19.247.521 | 21.793.614 | 22.153.638 | 62.625.456 | 81.046.590 | 67.650.594 | 24.228.561 | 33.905.631 |
| Creante | 168.638.265 | 177.650.519 | 210.728.039 | 203.299.222 | 230.680.528 | 209.172.633 | 244.485.451 | 277.019.793 | 53.371.516 | 455.547.021 |
| Casa si conturi | 230.954 | 2.510.686 | 195.034 | 243.511 | 464.434 | 1.969.228 | 536.355 | 3.279.044 | 36.388.978 | 60.303.128 |
| Capitaluri Proprii | 164.442.915 | 174.071.712 | 192.562.631 | 188.799.300 | 210.437.227 | 265.960.337 | 283.444.411 | 303.360.029 | 228.655.120 | 238.275.386 |
| Capital Social | 105.204.000 | 105.204.000 | 105.204.000 | 105.204.000 | 105.204.000 | 119.518.520 | 119.518.520 | 119.518.520 | 119.518.520 | 119.518.520 |
| Datorii | 138.428.761 | 143.310.140 | 162.635.474 | 171.075.143 | 171.557.290 | 162.927.508 | 221.912.227 | 216.962.998 | 46.454.746 | 463.158.751 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "2110 - 2110" | |||||||||
| CAEN An Financiar |
2110
|
|||||||||
Comentarii - Novartis Pharmaceuticals S.r.l.